BOTHELL, Wash., May 27 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) (OTC Bulletin Board: CCYG) today reaffirmed its commitment to provide shareholders, potential investors and journalists with accurate and up-to-date information by launching a comprehensive Investor Room powered Web site: http://www.cellcyte.com . Shareholders, investors and journalists seeking background information or sources for stories from CellCyte can access the information easily in the new Web site, which was designed to meet their needs quickly and efficiently.
CellCyte's Investor Room website includes corporate background materials, executive bios, SEC filings, stock charts, news releases, and links to news and Web sites on stem cell research. The multimedia capabilities of the Investor Room system will allow CellCyte to communicate in detail regarding its technology and development plans. Further, investors and journalists can opt-in to receive email alerts on news from CellCyte.
About CellCyte Genetics
CellCyte Genetics is a biotechnology company engaged in the discovery, development and commercialization of stem cell enabling therapeutic products. CellCyte is developing products designed to allow more efficient delivery and increased retention of adult stem cells to diseased organs, such as the heart. The goal of these therapies is to increase the number of stem cells delivered to a damaged organ, thereby markedly increasing organ healing and functional restoration. The Company's lead product in development, CCG-TH30, is designed to send autologous bone marrow-derived (adult) stem cells to the heart of patients after a heart attack.
For further information see: http://www.cellcyte.com .
Symbol: OTCBB - CCYG; Frankfurt/Berlin Symbol - LK6 WKN. No.: A0MLCV.
|SOURCE CellCyte Genetics Corporation|
Copyright©2008 PR Newswire.
All rights reserved